{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:32:10Z","timestamp":1792067530481,"version":"4.4.0"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T00:00:00Z","timestamp":1202688000000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:p><jats:bold>Background:\u2003<\/jats:bold> Women with preterm labour that is arrested with tocolytic therapy are at increased risk of recurrent preterm labour. The efficacy of maintenance tocolytic therapy after successful arrest of preterm labour remains controversial.<\/jats:p><jats:p><jats:bold>Aim:\u2003<\/jats:bold> The purpose of this study was to determine whether supplementation of vaginal progesterone after inhibition of preterm labour is associated with an increased latency period and a decreased recurrent of preterm labour.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> This trial was conducted in 70 women who presented with symptoms of threatened preterm labour, who after arrest of uterine activity were then randomised to progesterone therapy or no treatment. Treatment group received progesterone suppository (400\u00a0mg) daily until delivery and control group received no treatment.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> Longer mean latency until delivery (36\/11\u00a0\u00b1\u00a017\/9 vs 24\/52\u00a0\u00b1\u00a027\/2) (mean\u00a0+\u00a0standard deviation) days; respiratory distress syndrome 4 (10.8%) vs 12 (36.4%) <jats:italic>P<\/jats:italic>\u00a0=\u00a00.021; low birthweight 10 (27%) vs 17 (51.5%) <jats:italic>P<\/jats:italic>\u00a0=\u00a00.04; and birthweight (3101.54\u00a0\u00b1\u00a0587.9\u00a0g vs <jats:italic>r<\/jats:italic> 2609.39\u00a0\u00b1\u00a0662.9\u00a0g, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.002), were significantly different between the two groups.<\/jats:p><jats:p>No significant differences were found between recurrent preterm labour 13 (35.1%) vs 19 (57.6%),<jats:italic> P<\/jats:italic>\u00a0=\u00a00.092; admission to intensive care unit 9 (24.3%) vs 13 (39.4%), <jats:italic>P<\/jats:italic>= 0.205 ; and neonatal sepsis 2 (5.4%) vs 6 (18.2%) <jats:italic>P<\/jats:italic>\u00a0=\u00a00.136, for the progesterone and control groups, respectively.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> The use of vaginal progesterone suppository after successful parenteral tocolysis associated with a longer latency preceding delivery but failed to reduce the incidence of readmission for preterm labour.<\/jats:p>","DOI":"10.1111\/j.1479-828x.2007.00803.x","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T10:17:32Z","timestamp":1202725052000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomised controlled trial"],"prefix":"10.1111","volume":"48","author":[{"given":"Sedigheh","family":"BORNA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noshin","family":"SAHABI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,11]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036128"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","unstructured":"DoddJM CrowtherCA DareMR MiddletonP.Oral betamimetics for maintenance therapy after threatened preterm labor.Cochrane Database Syst Rev2006; (1):CD003927.","DOI":"10.1002\/14651858.CD003927.pub2"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70582-X"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00599.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","unstructured":"DayaS GunbyJ.Luteal phase support in assisted reproduction cycles.Cochrane Database Syst Rev2004; (1):CD004830.","DOI":"10.1002\/14651858.CD004830"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","unstructured":"Oates\u2010WhiteheadRM HaasDM CarrierJA.Progestogen for preventing miscarriage.Cochrane Database Syst Rev2003; (4):CD003511.","DOI":"10.1002\/14651858.CD003511"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.8.1944"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-4520.2006.00128.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2005.08.007"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(85)90141-3"},{"key":"e_1_2_5_12_2","unstructured":"DoddJM FlenadyV CincottaR CrowtherCA.Prenatal administration of progesterone for preventing preterm birth.Cochrane Database Syst Rev2006; (1):CD004947."},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.41"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035140"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067815"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070641"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(91)90118-5"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.09.009"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-522601-1.50008-1"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"C81","DOI":"10.1152\/ajpcell.1980.238.3.C81","article-title":"Gap junction formation in myometrium: Control by estrogens, progesterone, and prostaglandins","volume":"238","author":"Garfield RE","year":"1980","journal-title":"Am J Physiol"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/229208a0"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-55-6-1237"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1479-828X.2007.00803.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1479-828X.2007.00803.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T17:12:57Z","timestamp":1697130777000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1479-828X.2007.00803.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1479-828X.2007.00803.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1479-828x.2007.00803.x","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"2008-02-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}